![Jürgen Reess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jürgen Reess
Director/Board Member at
CYXONE AB
Profile
Jürgen Reess is the founder of Mogling Bio.
He is currently the Director at Cyxone AB and the Chief Marketing Officer at SciRhom GmbH.
Previously, he worked as the Managing Director at Cellerys AG.
He holds a doctorate degree from Universität Ulm.
Jürgen Reess active positions
| Companies | Position | Start |
|---|---|---|
| CYXONE AB | Director/Board Member | 01/01/2023 |
Mogling Bio
 Mogling Bio BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | - |
SciRhom GmbH
 SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Sales & Marketing | - |
Former positions of Jürgen Reess
| Companies | Position | End |
|---|---|---|
Cellerys AG
 Cellerys AG Miscellaneous Commercial ServicesCommercial Services Engages in conducting research on a therapy to fight multiple sclerosis | Chief Executive Officer | - |
Training of Jürgen Reess
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyxone AB
 Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
Mogling Bio
Mogling Bio BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cellerys AG
Cellerys AG Miscellaneous Commercial ServicesCommercial Services Engages in conducting research on a therapy to fight multiple sclerosis | Commercial Services |
- Stock Market
- Insiders
- Jürgen Reess
